Have your own idea? Try our Stock Screener
U.K. (FTSE) Biotech Industry Analysis
UpdatedFeb 08, 2026
DataAggregated Company Financials
Companies21
- 7D-2.9%
- 3M21.0%
- 1Y38.5%
- YTD16.6%
Over the last 7 days, the Biotech industry has dropped 2.9%, driven by a pullback from Genus of 4.0%. In contrast, Avacta Group has gained 17%. In the past year, the industry has gained 38%. As for the next few years, earnings are expected to grow by 32% per annum.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 08 Feb 2026 | UK£3.8b | UK£876.1m | -UK£28,317,825.88 | 10x | -133.3x | 4.3x |
| Tue, 06 Jan 2026 | UK£3.3b | UK£896.7m | -UK£29,614,400.98 | 10.5x | -110x | 3.6x |
| Thu, 04 Dec 2025 | UK£3.2b | UK£895.2m | -UK£30,976,771.57 | 10.2x | -103.8x | 3.6x |
| Sat, 01 Nov 2025 | UK£3.2b | UK£886.6m | -UK£43,008,938.18 | 11.2x | -74.8x | 3.6x |
| Mon, 29 Sep 2025 | UK£3.2b | UK£879.8m | -UK£68,834,067.23 | 16.5x | -46.5x | 3.6x |
| Wed, 27 Aug 2025 | UK£3.4b | UK£854.6m | -UK£105,312,305.08 | 12.4x | -32.4x | 4x |
| Fri, 25 Jul 2025 | UK£3.0b | UK£854.5m | -UK£103,347,574.19 | 13.5x | -29.1x | 3.5x |
| Sun, 22 Jun 2025 | UK£2.5b | UK£857.4m | -UK£103,811,791.00 | 12.6x | -24.2x | 2.9x |
| Tue, 20 May 2025 | UK£2.4b | UK£879.4m | -UK£91,741,400.50 | 13.1x | -26.5x | 2.8x |
| Thu, 17 Apr 2025 | UK£2.1b | UK£876.5m | -UK£169,868,509.34 | 16.3x | -12.5x | 2.4x |
| Sat, 15 Mar 2025 | UK£2.4b | UK£844.1m | -UK£277,312,399.01 | 18.4x | -8.6x | 2.8x |
| Mon, 10 Feb 2025 | UK£2.7b | UK£842.2m | -UK£295,469,562.04 | 84x | -9.1x | 3.2x |
| Wed, 08 Jan 2025 | UK£2.6b | UK£842.0m | -UK£294,886,372.28 | 73.8x | -8.7x | 3.1x |
| Fri, 06 Dec 2024 | UK£2.7b | UK£841.4m | -UK£293,358,592.62 | 81.2x | -9.2x | 3.2x |
| Sun, 03 Nov 2024 | UK£2.9b | UK£840.3m | -UK£292,959,775.31 | 99.1x | -10x | 3.5x |
| Tue, 01 Oct 2024 | UK£2.9b | UK£839.6m | -UK£292,021,398.66 | 94.9x | -9.8x | 3.4x |
| Thu, 29 Aug 2024 | UK£2.9b | UK£836.4m | -UK£276,161,817.77 | 30.3x | -10.3x | 3.4x |
| Sat, 27 Jul 2024 | UK£2.7b | UK£838.0m | -UK£257,183,406.00 | 31.1x | -10.6x | 3.3x |
| Mon, 24 Jun 2024 | UK£2.6b | UK£835.8m | -UK£273,591,160.91 | 29.8x | -9.6x | 3.2x |
| Wed, 22 May 2024 | UK£3.0b | UK£836.8m | -UK£287,640,856.44 | 31.6x | -10.4x | 3.6x |
| Fri, 19 Apr 2024 | UK£3.0b | UK£902.9m | -UK£201,712,961.59 | 28.8x | -15x | 3.4x |
| Sun, 17 Mar 2024 | UK£3.1b | UK£897.7m | -UK£203,570,600.75 | 34.3x | -15x | 3.4x |
| Tue, 13 Feb 2024 | UK£3.4b | UK£913.4m | -UK£197,968,131.65 | 31.2x | -17.1x | 3.7x |
| Thu, 11 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,164,691.00 | 37.2x | -26x | 5x |
| Sat, 09 Dec 2023 | UK£6.2b | UK£1.3b | -UK£245,982,366.00 | 36.9x | -25.1x | 4.9x |
| Mon, 06 Nov 2023 | UK£6.4b | UK£1.3b | -UK£242,972,491.00 | 39.9x | -26.5x | 5.1x |
| Wed, 04 Oct 2023 | UK£6.5b | UK£1.3b | -UK£251,254,741.00 | 36.7x | -25.8x | 5.1x |
| Fri, 01 Sep 2023 | UK£6.7b | UK£1.3b | -UK£205,584,814.00 | 23.6x | -32.5x | 5.3x |
| Sun, 30 Jul 2023 | UK£6.9b | UK£1.3b | -UK£208,643,030.00 | 23.6x | -33.2x | 5.5x |
| Tue, 27 Jun 2023 | UK£6.8b | UK£1.3b | -UK£205,388,309.00 | 23.9x | -33x | 5.4x |
| Thu, 25 May 2023 | UK£6.9b | UK£1.3b | -UK£207,220,434.00 | 23.2x | -33.5x | 5.5x |
| Sat, 22 Apr 2023 | UK£7.2b | UK£1.2b | -UK£156,369,449.00 | 23.5x | -45.9x | 5.8x |
| Mon, 20 Mar 2023 | UK£7.3b | UK£1.2b | -UK£157,945,091.00 | 25.7x | -46x | 5.9x |
| Wed, 15 Feb 2023 | UK£7.4b | UK£1.2b | -UK£149,734,163.00 | 28.9x | -49.7x | 6.4x |
Price to Earnings Ratio
-49.7x
Current Industry PE
- Investors are relatively neutral on the British Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 9.2% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | 1.13% | |
| Healthcare | 6.36% | |
| Biotech | -2.90% | |
| Biotech | -2.90% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AVCT Avacta Group | UK£0.60 | 17.5% +UK£39.4m | 30.1% | PS2341.9x | |
| HEMO Hemogenyx Pharmaceuticals | UK£11.00 | 49.5% +UK£22.0m | 216.5% | PE-8.5x | |
| 0KF3 Palatin Technologies | US$17.00 | 7.3% +US$2.0m | -68.9% | PS3.3x | |
| APTA Aptamer Group | UK£0.0092 | 5.7% +UK£1.3m | 125.6% | PS20.7x | |
| CRTX CRISM Therapeutics | UK£0.13 | 24.4% +UK£1.3m | 50.0% | PS263.8x |
